Lineal Earns Life Sciences and Pharmaceutical Industry Competencies from Relativity
KANSAS CITY, MO. – FEBRUARY 17 – Lineal, a global leader in data-driven eDiscovery, managed services, and legal technology innovation, today announced it has earned the Life Sciences and Pharmaceutical Industry Competencies from Relativity, a legal data intelligence company. With these competencies, Lineal reinforces its commitment to supporting life sciences and pharmaceutical organizations as they navigate complex litigation, regulatory inquiries, and investigations involving highly sensitive scientific, clinical and commercial data.
Partners with the Life Sciences Industry Competency have deep experience leveraging RelativityOne to meet the unique needs of the life sciences sector, streamlining discovery workflows and executing comprehensive investigations. Partners with the Pharmaceutical Industry Competency specialize in enabling pharmaceutical organizations to navigate legal complexities, including patent litigation and product liability challenges.
Lineal’s proprietary Amplify™ Suite, fully integrated with RelativityOne, works in combination with life sciences-specific workflows and senior subject-matter experts to help pharmaceutical organizations reduce review volumes, preserve scientific context and surface critical issues earlier in the matter lifecycle. When paired with Relativity aiR for Review, these workflows support consistent, explainable and defensible review outcomes in environments subject to intense regulatory scrutiny.
“Pharmaceutical organizations face discovery challenges that are genuinely different from other industries—the data is scientifically complex, the regulatory stakes are high, and the timelines are unforgiving,” said Brian Stempel, Head of Customer Advocacy at Lineal. “Lineal has built workflows within RelativityOne that address those realities directly. By combining our Amplify™ suite with the power of aiR for Review, we give clients a cost-controlled, defensible first-pass review process that outperforms traditional contract review on both speed and consistency.”
To earn these competencies, Lineal demonstrated a strong track record of leveraging RelativityOne to manage large, complex data populations for global pharmaceutical companies—while maintaining defensibility, auditability and regulatory alignment. This includes handling structured and unstructured data sources, cross-border data transfers, multilingual content and evolving collaboration platforms under aggressive regulatory and litigation timelines.
For more information about Lineal’s pharmaceutical industry solutions, visit https://lineal.com/pharmaceutical/.
_
About Lineal
About Lineal Founded in 2009, Lineal is a leader in eDiscovery, managed services, investigations, and legal technology innovation. The company’s comprehensive suite of services – including its work supporting pharmaceutical and life sciences organizations with complex scientific and regulatory data workflows and its newly earned Relativity Life Sciences and Pharmaceutical Industry Competency – and groundbreaking solutions like Amplify™ enable legal teams to tackle their most complex data challenges with confidence. A global company, Lineal operates in the United States, United Kingdom, United Arab Emirates, Germany, Switzerland, Brazil, India, China, Hong Kong, and Singapore. Learn more at www.lineal.com.
_
About Relativity
Relativity is a leading legal data intelligence company that builds technology to help users organize data, discover the truth, and act on it. Its extensible, AI-powered cloud platform, RelativityOne, transforms complex data into actionable insights at massive scale for litigation, investigations, regulatory inquiries, data breach responses, and other legal use cases. The world’s largest law firms and corporations, government agencies, and a robust network of channel partners rely on Relativity’s legal AI software to securely surface and manage the most relevant and impactful information in their matters. The company also expands access to technology by providing its platform at no cost to academic institutions through its Relativity Academic program and to organizations supporting pro bono legal work through its Justice for Change initiative.